文献速递冠心病

临床风险预测、冠脉CT血管成像与新发胸痛的心血管事件:PROMISE与SCOT-HEART试验

Clinical risk prediction, coronary computed tomography angiography, and cardiovascular events in new-onset chest pain: the PROMISE and SCOT-HEART trials.
PubMed 文献 · Eur Heart J · 2025-01-01

总体事件率相近,但RF-CL低危组接受冠脉CTA者事件率更低,而极低危与中/高危组无差异。

要点

  • 低RF-CL(>5%-15%)稳定性胸痛患者初始冠脉CTA较常规诊疗降低3年心梗或死亡风险。
  • 极低危与中/高危RF-CL患者中冠脉CTA与常规诊疗事件风险相似。
  • 冠脉CTA预防1例3年事件需检测的人数(NNT)为143。

核心结论

  • 在稳定性胸痛患者中,冠脉CTA总体上未显著降低3年心肌梗死或死亡风险,但低RF-CL患者可从初始冠脉CTA中获益。

研究设计与样本

  • 患者按风险因素加权临床可能性(RF-CL)分为极低危(≤5%)、低危(>5%-15%)和中/高危(>15%)三层,主要终点为3年心肌梗死或死亡。

主要发现

  • 主要终点共发生313例(2.3%);冠脉CTA组与常规诊疗组事件率相似,风险差(RD)0.3%,风险比(HR)0.84(95%CI 0.67-1.05)。
  • 极低危与中/高危RF-CL患者中冠脉CTA与常规诊疗风险相似:极低危RD 0.3%、HR 1.27(0.74-2.16);中/高危RD 0.5%、HR 0.88(0.63-1.23)。
  • 低RF-CL患者接受冠脉CTA后事件率更低:RD 0.7%,HR 0.67(95%CI 0.47-0.97)。

关键数值与推荐

  • RF-CL分层阈值:极低危≤5%,低危>5%-15%,中/高危>15%。
  • 使用冠脉CTA预防1例3年内事件所需检测人数为143。

临床怎么用

  • 对稳定性胸痛患者可先用RF-CL模型分层,低危(>5%-15%)者初始选择冠脉CTA可能降低3年心梗或死亡风险。
  • 极低危与中/高危患者中冠脉CTA与常规诊疗事件风险相近,选择检查策略时应结合分层结果个体化决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Whether index testing using coronary computed tomography angiography (CTA) improves outcomes in stable chest pain is debated. The risk factor weighted clinical likelihood (RF-CL) model provides likelihood estimation of obstructive coronary artery disease. This study investigated the prognostic effect of coronary CTA vs. usual care by RF-CL estimates. METHODS: Large-scale studies randomized patients (N = 13 748) with stable chest pain to coronary CTA as part of the initial work-up in addition to or instead of usual care including functional testing. Patients were stratified according to RF-CL estimates [RF-CL: very-low (≤5%), low (>5%-15%), and moderate/high (>15%)]. The primary endpoint was myocardial infarction or death at 3 years. RESULTS: The primary endpoint occurred in 313 (2.3%) patients. Event rates were similar in patients allocated to coronary CTA vs. usual care [risk difference (RD) 0.3%, hazard ratio (HR) 0.84 (95% CI 0.67-1.05)]. Overall, 33%, 44%, and 23% patients had very-low, low, and moderate/high RF-CL. Risk was similar in patients with very low and moderate/high RF-CL allocated to coronary CTA vs. usual care [very low: RD 0.3%, HR 1.27 (0.74-2.16); moderate/high: RD 0.5%, HR 0.88 (0.63-1.23)]. Conversely, patients with low RF-CL undergoing coronary CTA had lower event rates [RD 0.7%, HR 0.67 (95% CI 0.47-0.97)]. The number needed to test using coronary CTA to prevent one event within 3 years was 143. CONCLUSIONS: Despite an overall good prognosis, low RF-CL patients have reduced risk of myocardial infarction or death when allocated to coronary CTA vs. usual care. Risk is similar in patients with very-low and moderate/high likelihood.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Rasmussen, Schmidt, Knuuti, et al. Clinical risk prediction, coronary computed tomography angiography, and cardiovascular events in new-onset chest pain: the PROMISE and SCOT-HEART trials. Eur Heart J. 2025. PMID: 39453783. doi:10.1093/eurheartj/ehae742

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。